Guggenheim
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
Coverage of Guggenheim is holding steady : 3 signals on the latest tracked day, level with its three-week baseline of 3, across 2 domains.
Guggenheim is steady by its own history. Its normal rhythm is about 3 signals a day across 2 domains. A real move would be a day at 4+ signals — 25% above that baseline, the bar our trend read calls accelerating — or a spread into domains beyond its usual 2. That is the move that would push it up the Wire.
What’s changed
- Nykredit A S Invests $9.69 Million in Insmed, Inc. $INSM · MarketBeat News Feed · 2026-09-21
- Italy’s private equity weekly roundup. News from newcleo, NewHold, Trevi, Webuild, and more · BeBeez International · 2026-09-21
- Cantor Fitzgerald Forecasts Strong Price Appreciation for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock · MarketBeat News Feed · 2026-09-18
- Oracle’s 2026 Cratering: This Pro Is Sure It Will Nearly Triple in the Next 12 Months · 24/7 Wall St. · 2026-09-17
- Ultragenyx Pharmaceutical (NASDAQ:RARE) CAO Theodore Alan Huizenga Sells 1,283 Shares of Stock · MarketBeat News Feed · 2026-09-16
- Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More · 24/7 Wall St. · 2026-09-15
What the reporting says
It shows up alongside Strong Buy (10), Nasdaq (13), SEC (12), Wall Street (11), Exchange Commission (10), Marketbeat (8).
Two steps out: AI (through Nasdaq, 13 shared stories on the weaker link); Crypto (through Nasdaq, 13 shared stories on the weaker link); Gaap (through Nasdaq, 13 shared stories on the weaker link); Inflation (through Nasdaq, 13 shared stories on the weaker link).
Tracked since Apr 26, with coverage on 20 separate days — concentrated in Rare Diseases and Auto.